Discovery of an AKT Degrader with Prolonged Inhibition of Downstream Signaling
{{output}}
The PI3K/AKT signaling cascade is one of the most commonly dysregulated pathways in cancer, with over half of tumors exhibiting aberrant AKT activation. Although potent small-molecule AKT inhibitors have entered clinical trials, robust and durable therapeutic ... ...
